ArticleCancer chemotherapy and pharmacology2025

Pharmacokinetic exposure and treatment outcomes of lenvatinib in patients with renal cell carcinoma and differentiated thyroid carcinoma.

Marinda Meertens et al.PubMed ↗Publisher ↗

No numbers read from the abstract.